Actively Recruiting

Age: 18Years +
All Genders
ID07510984

Prevalence and Characterization of Dysphagia and Dyspepsia Symptoms and Assessment of Quality of Life in Heterotopic Gastric Mucosa (HGM)

Led by Knappschaft Kliniken GmbH · Updated on 2026-04-14

721

Participants Needed

1

Research Sites

14 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether heterotopic gastric mucosa (HGM), which are islands of stomach-like tissue in the upper esophagus, is linked to swallowing difficulties (dysphagia) in adults undergoing medically needed gastroscopy. The study also looks at connections between HGM and indigestion symptoms (dyspepsia) and their impact on quality of life. Participants with and without HGM will be compared to see if symptoms and quality-of-life measures differ between these groups. This is a prospective, observational study involving adults aged 18 and older who are scheduled for gastroscopy for any medical reason. Before the procedure, participants fill out questionnaires about dysphagia, dyspepsia, and quality of life. During the planned gastroscopy, doctors check for HGM without influencing the procedure. No extra procedures are required beyond the routine gastroscopy and any clinical tissue sampling. Participants complete detailed symptom and quality-of-life questionnaires before gastroscopy. The study collects data on swallowing difficulties, indigestion symptoms, and health-related quality of life using validated tools. The presence of HGM is recorded during routine endoscopy without revealing questionnaire answers to the doctor. Data will be analyzed to understand the relationship between HGM and symptoms. Total participation involves a single assessment before gastroscopy, with no additional follow-up required.

CONDITIONS

Brief Title

Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Planned upper gastrointestinal endoscopy (gastroscopy) for clinical reasons (any indication)
  • Age 18 years or older
  • Written informed consent
  • Ability to complete the study questionnaires before endoscopy
Not Eligible

You will not qualify if you...

  • Previously known heterotopic gastric mucosa (HGM)
  • Previously diagnosed swallowing difficulties with prior treatment such as diet modification, nutrition support, steroid therapy, or botulinum toxin injection
  • Mechanical ventilation
  • Presence of a tracheostomy
  • Inadequate endoscopic access or visibility of the proximal esophagus
  • General condition insufficient for careful endoscopic inspection
  • Increased risk of aspiration
  • Complications preventing careful inspection of the proximal esophagus
  • History of surgery involving the pharynx or esophagus
  • Severe neurological disorders like ALS or stroke
  • Severe dementia
  • Severe depressive disorder
  • Inability or unwillingness to comply with study procedures
  • Planned PEG placement
  • Emergency endoscopy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for informed consent and questionnaire completion prior to gastroscopy

Diagnostic Evaluation

Duration - Single day

Participants undergo routine upper gastrointestinal endoscopy to inspect the proximal esophagus for heterotopic gastric mucosa (HGM). No additional procedures beyond routine care are performed.

1 visit (in-person) for clinically indicated gastroscopy

Long-term Monitoring

Duration - Up to 12 months

Participants' symptoms and quality of life related to dysphagia and dyspepsia are assessed through questionnaires completed at baseline prior to endoscopy. Participants are observed based on routine clinical data and any histology available from routine care.

No additional study visits; data collected from routine care and questionnaires

Trial Site Locations

Total: 1 location

1

Knappschaftskrankenhaus Bottrop

Bottrop, North Rhine-Westphalia, Germany, 46240

Actively Recruiting

Loading map...

Research Team

F

Felix Horstmann, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here